Matches in SemOpenAlex for { <https://semopenalex.org/work/W4290995002> ?p ?o ?g. }
- W4290995002 endingPage "4785" @default.
- W4290995002 startingPage "4771" @default.
- W4290995002 abstract "Few studies have focused on the subclinical cardiotoxicity of immune checkpoint inhibitors (ICIs) in cancer patients. This study aimed to evaluate the manifestations of subclinical cardiotoxicity of ICI therapy using cardiovascular magnetic resonance (CMR) and to explore whether CMR parameters can help predict cardiotoxicity at the early stage of ICI therapy.A prospective, longitudinal study was conducted among patients with lung cancer. The patients were planned to undergo serial CMRs before (baseline), 3 weeks after (1st follow-up), and 3 months after (2nd follow-up) the initiation of ICI therapy, respectively. Patients with 3 CMRs were included in the analysis. Serial quantitative measurements based on CMR were compared using one-way repeated measures analysis of variance (RM-ANOVA). On the basis of cancer therapy-related cardiac dysfunction (CTRCD) observed at the second follow-up, patients were categorized into a CTRCD group and a non-CTRCD group. Baseline clinical and CMR parameters and the relative reduction of left ventricular global strain at the second follow-up was compared between the CTRCD group and the non-CTRCD group. Receiver operating characteristic (ROC) analysis was used to identify CTRCD that developed 3 months after ICI therapy.A total of 36 patients with 3 CMRs (60.7±9.2 years old, 77.8% male) were included in the analysis. Left ventricular-global radial strain (LV-GRS) decreased significantly at the second follow-up (37.9%±8.5% vs. 33.1%±1.0%; P=0.014), but left ventricular ejection fraction (LVEF) did not change significantly (51.5%±6.0% vs. 49.2%±6.5%; P>0.05). A total of 7 patients (19.4%) had developed CTRCD by the second follow-up. Baseline clinical and CMR parameters did not differ between the CTRCD group and the non-CTRCD group (P>0.05 for all). In the CTRCD group, the left ventricular-global circumferential strains (LV-GCSs) showed significant reductions at both the first and second follow-up (P=0.008 and 0.035, respectively), but the LVEF only showed a significant reduction at the second follow-up (P<0.001). The relative reduction of LV-GRS at the second follow-up was significantly higher in the CTRCD group than in the non-CTRCD group (29.8%±25.8% vs. 6.8%±20.4%; P=0.036) and was used to predict CTRCD developed at the 3-month timepoint after ICI therapy [area under the curve (AUC) =0.759; P=0.036].In the early stage of ICI therapy, assessment of myocardial strain can be used to detect subclinical left ventricular systolic dysfunction in patients with lung cancer earlier than LVEF. The relative reduction of LV-GRS can be used to predict CTRCD 3 months after ICI therapy." @default.
- W4290995002 created "2022-08-13" @default.
- W4290995002 creator A5009017779 @default.
- W4290995002 creator A5011621317 @default.
- W4290995002 creator A5015401166 @default.
- W4290995002 creator A5017371410 @default.
- W4290995002 creator A5032087142 @default.
- W4290995002 creator A5037178585 @default.
- W4290995002 creator A5038108244 @default.
- W4290995002 creator A5055068824 @default.
- W4290995002 creator A5056674934 @default.
- W4290995002 creator A5057117256 @default.
- W4290995002 creator A5062637798 @default.
- W4290995002 creator A5066685111 @default.
- W4290995002 creator A5084779086 @default.
- W4290995002 date "2022-10-01" @default.
- W4290995002 modified "2023-10-12" @default.
- W4290995002 title "Early evaluation of subclinical cardiotoxicity in patients with lung cancer receiving immune checkpoint inhibitors by cardiovascular magnetic resonance: a prospective observational study" @default.
- W4290995002 cites W1973955570 @default.
- W4290995002 cites W1975578701 @default.
- W4290995002 cites W2039057919 @default.
- W4290995002 cites W2095455190 @default.
- W4290995002 cites W2098108524 @default.
- W4290995002 cites W2119078839 @default.
- W4290995002 cites W2130011407 @default.
- W4290995002 cites W2339890238 @default.
- W4290995002 cites W2508734629 @default.
- W4290995002 cites W2547133566 @default.
- W4290995002 cites W2739626421 @default.
- W4290995002 cites W2769632314 @default.
- W4290995002 cites W2789315292 @default.
- W4290995002 cites W2791670199 @default.
- W4290995002 cites W2793167197 @default.
- W4290995002 cites W2801582053 @default.
- W4290995002 cites W2804734521 @default.
- W4290995002 cites W2888880602 @default.
- W4290995002 cites W2901191795 @default.
- W4290995002 cites W2969461497 @default.
- W4290995002 cites W2999536665 @default.
- W4290995002 cites W3004876296 @default.
- W4290995002 cites W3007666278 @default.
- W4290995002 cites W3008757291 @default.
- W4290995002 cites W3009715213 @default.
- W4290995002 cites W3026324639 @default.
- W4290995002 cites W3047192227 @default.
- W4290995002 cites W3120932526 @default.
- W4290995002 cites W3125491269 @default.
- W4290995002 cites W3133177137 @default.
- W4290995002 cites W3138063070 @default.
- W4290995002 cites W3157388029 @default.
- W4290995002 cites W3169765738 @default.
- W4290995002 cites W3188167194 @default.
- W4290995002 cites W3191490274 @default.
- W4290995002 cites W3203533569 @default.
- W4290995002 cites W4206685154 @default.
- W4290995002 doi "https://doi.org/10.21037/qims-22-41" @default.
- W4290995002 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36185042" @default.
- W4290995002 hasPublicationYear "2022" @default.
- W4290995002 type Work @default.
- W4290995002 citedByCount "2" @default.
- W4290995002 countsByYear W42909950022023 @default.
- W4290995002 crossrefType "journal-article" @default.
- W4290995002 hasAuthorship W4290995002A5009017779 @default.
- W4290995002 hasAuthorship W4290995002A5011621317 @default.
- W4290995002 hasAuthorship W4290995002A5015401166 @default.
- W4290995002 hasAuthorship W4290995002A5017371410 @default.
- W4290995002 hasAuthorship W4290995002A5032087142 @default.
- W4290995002 hasAuthorship W4290995002A5037178585 @default.
- W4290995002 hasAuthorship W4290995002A5038108244 @default.
- W4290995002 hasAuthorship W4290995002A5055068824 @default.
- W4290995002 hasAuthorship W4290995002A5056674934 @default.
- W4290995002 hasAuthorship W4290995002A5057117256 @default.
- W4290995002 hasAuthorship W4290995002A5062637798 @default.
- W4290995002 hasAuthorship W4290995002A5066685111 @default.
- W4290995002 hasAuthorship W4290995002A5084779086 @default.
- W4290995002 hasBestOaLocation W42909950021 @default.
- W4290995002 hasConcept C113280763 @default.
- W4290995002 hasConcept C121608353 @default.
- W4290995002 hasConcept C126322002 @default.
- W4290995002 hasConcept C164705383 @default.
- W4290995002 hasConcept C188816634 @default.
- W4290995002 hasConcept C2776694085 @default.
- W4290995002 hasConcept C2778198053 @default.
- W4290995002 hasConcept C2778233292 @default.
- W4290995002 hasConcept C71924100 @default.
- W4290995002 hasConcept C78085059 @default.
- W4290995002 hasConceptScore W4290995002C113280763 @default.
- W4290995002 hasConceptScore W4290995002C121608353 @default.
- W4290995002 hasConceptScore W4290995002C126322002 @default.
- W4290995002 hasConceptScore W4290995002C164705383 @default.
- W4290995002 hasConceptScore W4290995002C188816634 @default.
- W4290995002 hasConceptScore W4290995002C2776694085 @default.
- W4290995002 hasConceptScore W4290995002C2778198053 @default.
- W4290995002 hasConceptScore W4290995002C2778233292 @default.
- W4290995002 hasConceptScore W4290995002C71924100 @default.
- W4290995002 hasConceptScore W4290995002C78085059 @default.
- W4290995002 hasIssue "10" @default.
- W4290995002 hasLocation W42909950021 @default.